We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $47.5M
1-Year Est. Return 115.72%
This Fund
S&P 500
This Quarter Est. Return
-7.52%
1 Year Est. Return
+115.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$48.9M
Cap. Flow
-$18M
Cap. Flow %
-7.22%
Top 10 Hldgs %
27.41%
Holding
148
New
29
Increased
17
Reduced
14
Closed
22

Top Buys

Rank Stock Value
1
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.25M
2
GH icon
Guardant Health
GH
+$5.2M
3
STAA icon
STAAR Surgical
STAA
+$4.83M
4
INGN icon
Inogen
INGN
+$4.14M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$3.53M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$7.56M
2
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.23M
3
GMED icon
Globus Medical
GMED
+$5.83M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$5.82M
5
BCYC
Bicycle Therapeutics
BCYC
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 75.13%
2 Financials 11.69%
3 Miscellaneous 9.98%
4 Industrials 1.28%
5 Technology 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
1
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$10.8M 4.3%
615,000
+70,000
+13% +$1.1M
BLU
2
DELISTED
BELLUS Health Inc.
BLU
$8.43M 3.37%
912,000
-538,006
-37% -$4.4M
ADMA icon
3
ADMA Biologics
ADMA
$2.07B
$7.92M 3.17%
4,000,000
+700,000
+21% +$1.38M
ESPR
4
DELISTED
Esperion Therapeutics
ESPR
$7.4M 2.96%
1,162,869
-1,333,655
-53% -$7.56M
PEPL
5
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$7.25M 2.9%
+735,000
New +$7.25M
LNTH icon
6
Lantheus
LNTH
$6.55B
$5.81M 2.33%
88,000
+48,000
+120% +$3.03M
STAA icon
7
STAAR Surgical
STAA
$1.14B
$5.32M 2.13%
+75,000
New +$4.83M
INSM icon
8
Insmed
INSM
$28.3B
$5.29M 2.11%
268,000
– –
GKOS icon
9
Glaukos
GKOS
$9.87B
$5.18M 2.07%
114,000
+20,000
+21% +$949K
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$5.16M 2.07%
1,750,000
– –
MBTC
11
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$5.09M 2.04%
500,000
– –
QDEL icon
12
QuidelOrtho
QDEL
$808M
$4.86M 1.94%
50,000
-6,000
-11% -$612K
INSP icon
13
Inspire Medical Systems
INSP
$2.11B
$4.38M 1.75%
24,000
+8,000
+50% +$1.6M
ITCI
14
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.28M 1.71%
75,000
+52,500
+233% +$2.98M
GH icon
15
Guardant Health
GH
$21.1B
$4.24M 1.7%
+105,000
New +$5.2M
GH icon
16
CALL
Guardant Health
GH
$21.1B
$4.03M 1.61%
+100,000
New +$4.95M
MYGN icon
17
Myriad Genetics
MYGN
$327M
$4.02M 1.61%
221,000
+106,290
+93% +$2.21M
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
$3.96M 1.59%
+160,000
New +$3.53M
EUCR
19
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$3.96M 1.58%
400,000
– –
NVRO
20
DELISTED
NEVRO CORP.
NVRO
$3.9M 1.56%
89,000
+12,000
+16% +$660K
AMLX icon
21
PUT
Amylyx Pharmaceuticals
AMLX
$3.52B
$3.85M 1.54%
+200,000
New +$2.37M
AKYA
22
DELISTED
Akoya BioSciences
AKYA
$3.8M 1.52%
+296,000
New +$3.07M
INGN icon
23
Inogen
INGN
$141M
$3.77M 1.51%
+156,000
New +$4.14M
TRVI icon
24
Trevi Therapeutics
TRVI
$2.27B
$3.61M 1.44%
+1,284,000
New +$3.15M
VSTM icon
25
Verastem
VSTM
$663M
$3.48M 1.39%
250,000
+4,083
+2% +$65K
1
2 3 4 5

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $47.4M AUM 1.28% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $47.4M AUM 177.04% 1-Year Est. Return
YEPX
Yorktown Energy Partners X New York $47.6M AUM 46.93% 1-Year Est. Return
OGC
One68 Global Capital New York $47.2M AUM 6.52% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BJB
Broadhurst Jeffrey B $47M AUM
NA
Novus Advisors Greenville, South Carolina $48M AUM 17.82% 1-Year Est. Return

Altium Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Altium Capital Management held 148 positions worth $250M, down 16% from $299M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management withdrew a net $18M in Q2 2022, closing 22 positions and reducing 14 holdings. Its most notable exit was PepperLime Health Acquisition Corporation Unit, an estimated $7.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 79% a quarter earlier, followed by Financials and Miscellaneous.

Against the trend, Altium Capital Management opened a new position in PepperLime Health Acquisition Corporation Class A Ordinary Share worth $7.25M.

  • Altium Capital Management's largest Q2 2022 buy was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M.
  • Altium Capital Management added most to Lantheus in Q2 2022, an estimated $3.03M increase.
  • Altium Capital Management's biggest Q2 2022 reduction was Esperion Therapeutics, cutting an estimated $7.56M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Unit in Q2 2022, selling an estimated $7.23M.
  • Altium Capital Management's ten largest holdings make up 27% of its $250M portfolio in Q2 2022.
  • Altium Capital Management opened 29 new positions and closed 22 in Q2 2022.
  • Altium Capital Management's portfolio value fell 16% quarter-over-quarter to $250M.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.